Regulated unmasking of the cryptic binding site for integrin αMβ2 in the γC-domain of fibrinogen

Valeryi K. Lishko, Bohdan Kudryk, Valentin P. Yakubenko, Vivien C. Yee, Tatiana Ugarova

Research output: Contribution to journalArticle

76 Citations (Scopus)

Abstract

Fibrinogen is a ligand for leukocyte integrin αMβ2 (CD11b/CD18, Mac-1) and mediates adhesion and migration of leukocytes during the immune-inflammatory responses. The binding site for αMβ2 resides in γC, a constituent subdomain in the D-domain of fibrinogen. The sequence γ383-395 (P2-C) in γC was implicated as the major binding site for αMβ2. It is unknown why αMβ2 on leukocytes can bind to immobilized fibrinogen in the presence of high concentrations of soluble fibrinogen in plasma. In this study, we have investigated the accessibility of the binding site in fibrinogen for αMβ2. We found that the αMβ2-binding site in γC is cryptic and identified the mechanism that regulates its unmasking. Proteolytic removal of the small COOH-terminal segment(s) of γC, γ397/405-411, converted the D100 fragment of fibrinogen, which contains intact γC and is not able to inhibit adhesion of the αMβ2-expressing cells, into the fragment D98, which effectively inhibited cell adhesion. D98, but not D100, bound to the recombinant αMI-domain, and the αMI-domain recognition peptide, αM(Glu253-Arg261). Exposure of the P2-C sequence in fibrinogen, D100, and D98 was probed with a site-specific mAb. P2-C is not accessible in soluble fibrinogen and D100 but becomes exposed in D98. P2-C is also unmasked by immobilization of fibrinogen onto a plastic and by deposition of fibrinogen in the extracellular matrix. Thus, exposure of P2-C by immobilization and by proteolysis correlates with unmasking of the αMβ2-binding site in the D-domain. These results demonstrate that conformational alterations regulate the αMβ2-binding site in γC and suggest that processes relevant to tissue injury and inflammation are likely to be involved in the activation of the αMβ2-binding site in fibrinogen.

Original languageEnglish (US)
Pages (from-to)12942-12951
Number of pages10
JournalBiochemistry
Volume41
Issue number43
DOIs
StatePublished - Oct 29 2002
Externally publishedYes

Fingerprint

Integrins
Fibrinogen
Binding Sites
Leukocytes
Immobilization
Adhesion
Proteolysis
Cell adhesion
Cell Adhesion
Plastics
Extracellular Matrix
Chemical activation
Tissue
Ligands
Inflammation
Plasmas
Wounds and Injuries

ASJC Scopus subject areas

  • Biochemistry

Cite this

Regulated unmasking of the cryptic binding site for integrin αMβ2 in the γC-domain of fibrinogen. / Lishko, Valeryi K.; Kudryk, Bohdan; Yakubenko, Valentin P.; Yee, Vivien C.; Ugarova, Tatiana.

In: Biochemistry, Vol. 41, No. 43, 29.10.2002, p. 12942-12951.

Research output: Contribution to journalArticle

Lishko, Valeryi K. ; Kudryk, Bohdan ; Yakubenko, Valentin P. ; Yee, Vivien C. ; Ugarova, Tatiana. / Regulated unmasking of the cryptic binding site for integrin αMβ2 in the γC-domain of fibrinogen. In: Biochemistry. 2002 ; Vol. 41, No. 43. pp. 12942-12951.
@article{f632f93f6ca74e5884b1a96ff7ada89e,
title = "Regulated unmasking of the cryptic binding site for integrin αMβ2 in the γC-domain of fibrinogen",
abstract = "Fibrinogen is a ligand for leukocyte integrin αMβ2 (CD11b/CD18, Mac-1) and mediates adhesion and migration of leukocytes during the immune-inflammatory responses. The binding site for αMβ2 resides in γC, a constituent subdomain in the D-domain of fibrinogen. The sequence γ383-395 (P2-C) in γC was implicated as the major binding site for αMβ2. It is unknown why αMβ2 on leukocytes can bind to immobilized fibrinogen in the presence of high concentrations of soluble fibrinogen in plasma. In this study, we have investigated the accessibility of the binding site in fibrinogen for αMβ2. We found that the αMβ2-binding site in γC is cryptic and identified the mechanism that regulates its unmasking. Proteolytic removal of the small COOH-terminal segment(s) of γC, γ397/405-411, converted the D100 fragment of fibrinogen, which contains intact γC and is not able to inhibit adhesion of the αMβ2-expressing cells, into the fragment D98, which effectively inhibited cell adhesion. D98, but not D100, bound to the recombinant αMI-domain, and the αMI-domain recognition peptide, αM(Glu253-Arg261). Exposure of the P2-C sequence in fibrinogen, D100, and D98 was probed with a site-specific mAb. P2-C is not accessible in soluble fibrinogen and D100 but becomes exposed in D98. P2-C is also unmasked by immobilization of fibrinogen onto a plastic and by deposition of fibrinogen in the extracellular matrix. Thus, exposure of P2-C by immobilization and by proteolysis correlates with unmasking of the αMβ2-binding site in the D-domain. These results demonstrate that conformational alterations regulate the αMβ2-binding site in γC and suggest that processes relevant to tissue injury and inflammation are likely to be involved in the activation of the αMβ2-binding site in fibrinogen.",
author = "Lishko, {Valeryi K.} and Bohdan Kudryk and Yakubenko, {Valentin P.} and Yee, {Vivien C.} and Tatiana Ugarova",
year = "2002",
month = "10",
day = "29",
doi = "10.1021/bi026324c",
language = "English (US)",
volume = "41",
pages = "12942--12951",
journal = "Biochemistry",
issn = "0006-2960",
publisher = "American Chemical Society",
number = "43",

}

TY - JOUR

T1 - Regulated unmasking of the cryptic binding site for integrin αMβ2 in the γC-domain of fibrinogen

AU - Lishko, Valeryi K.

AU - Kudryk, Bohdan

AU - Yakubenko, Valentin P.

AU - Yee, Vivien C.

AU - Ugarova, Tatiana

PY - 2002/10/29

Y1 - 2002/10/29

N2 - Fibrinogen is a ligand for leukocyte integrin αMβ2 (CD11b/CD18, Mac-1) and mediates adhesion and migration of leukocytes during the immune-inflammatory responses. The binding site for αMβ2 resides in γC, a constituent subdomain in the D-domain of fibrinogen. The sequence γ383-395 (P2-C) in γC was implicated as the major binding site for αMβ2. It is unknown why αMβ2 on leukocytes can bind to immobilized fibrinogen in the presence of high concentrations of soluble fibrinogen in plasma. In this study, we have investigated the accessibility of the binding site in fibrinogen for αMβ2. We found that the αMβ2-binding site in γC is cryptic and identified the mechanism that regulates its unmasking. Proteolytic removal of the small COOH-terminal segment(s) of γC, γ397/405-411, converted the D100 fragment of fibrinogen, which contains intact γC and is not able to inhibit adhesion of the αMβ2-expressing cells, into the fragment D98, which effectively inhibited cell adhesion. D98, but not D100, bound to the recombinant αMI-domain, and the αMI-domain recognition peptide, αM(Glu253-Arg261). Exposure of the P2-C sequence in fibrinogen, D100, and D98 was probed with a site-specific mAb. P2-C is not accessible in soluble fibrinogen and D100 but becomes exposed in D98. P2-C is also unmasked by immobilization of fibrinogen onto a plastic and by deposition of fibrinogen in the extracellular matrix. Thus, exposure of P2-C by immobilization and by proteolysis correlates with unmasking of the αMβ2-binding site in the D-domain. These results demonstrate that conformational alterations regulate the αMβ2-binding site in γC and suggest that processes relevant to tissue injury and inflammation are likely to be involved in the activation of the αMβ2-binding site in fibrinogen.

AB - Fibrinogen is a ligand for leukocyte integrin αMβ2 (CD11b/CD18, Mac-1) and mediates adhesion and migration of leukocytes during the immune-inflammatory responses. The binding site for αMβ2 resides in γC, a constituent subdomain in the D-domain of fibrinogen. The sequence γ383-395 (P2-C) in γC was implicated as the major binding site for αMβ2. It is unknown why αMβ2 on leukocytes can bind to immobilized fibrinogen in the presence of high concentrations of soluble fibrinogen in plasma. In this study, we have investigated the accessibility of the binding site in fibrinogen for αMβ2. We found that the αMβ2-binding site in γC is cryptic and identified the mechanism that regulates its unmasking. Proteolytic removal of the small COOH-terminal segment(s) of γC, γ397/405-411, converted the D100 fragment of fibrinogen, which contains intact γC and is not able to inhibit adhesion of the αMβ2-expressing cells, into the fragment D98, which effectively inhibited cell adhesion. D98, but not D100, bound to the recombinant αMI-domain, and the αMI-domain recognition peptide, αM(Glu253-Arg261). Exposure of the P2-C sequence in fibrinogen, D100, and D98 was probed with a site-specific mAb. P2-C is not accessible in soluble fibrinogen and D100 but becomes exposed in D98. P2-C is also unmasked by immobilization of fibrinogen onto a plastic and by deposition of fibrinogen in the extracellular matrix. Thus, exposure of P2-C by immobilization and by proteolysis correlates with unmasking of the αMβ2-binding site in the D-domain. These results demonstrate that conformational alterations regulate the αMβ2-binding site in γC and suggest that processes relevant to tissue injury and inflammation are likely to be involved in the activation of the αMβ2-binding site in fibrinogen.

UR - http://www.scopus.com/inward/record.url?scp=0037195265&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037195265&partnerID=8YFLogxK

U2 - 10.1021/bi026324c

DO - 10.1021/bi026324c

M3 - Article

VL - 41

SP - 12942

EP - 12951

JO - Biochemistry

JF - Biochemistry

SN - 0006-2960

IS - 43

ER -